INSPECS Group plc

87.50pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:SPECHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 7Y CAGR (11.20%)
Div yield —
ROE (4.17%)
Medical Instruments & Supplies
Beta (5Y) 1.64
PE TTM —
TSR TTM 41.13%
Mkt cap £95.53M
ROIC 7.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
105p
20.22%
(74.87%)
Hold 3|6|6|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.74
0.72
0.71
0.69
4.19%
4.72%
1.17%
(6.53%)
Revenue£M
7.891
8.154
8.001
8.424
(3.19%)
2.30%
2.22%
8.96%
Peers (US$127.8M)
Cap (US$)
PE
825.5M
171.0x
250.7M
23.39x
140.6M
42.87x
Capital
TTM
5Y
10Y
Leveragex
2.561
(0.015)
(0.013)
EBIT/Intx
2.194
0.413
0.408
Own earn%
7.54
242.52
142.96
Sh yield%
37.63
70.18
67.91
Owners
Insiders/Inst%
6.02
27.51
Short interest%
4.96
SBC / revenue%
2.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
19–27
$1 testx
—
Incr. ROIC%
4